ARTICLE | Clinical News
AP-CBD/THC: Ph I started
March 24, 2017 8:16 PM UTC
Intec began a 3-way crossover, Israeli Phase I trial to evaluate 2 formulations of AP-CBD/THC compared to sublingual cannabis extract spray Sativex nabiximols in 21 healthy volunteers....
BCIQ Company Profiles